Stocks · Health care · Pharmaceutical Preparations

Biohaven Ltd.

BHVN Clue Score30
United States Fiscal year ends December CIK 0001935979 Results filed 29 Oct 2026

What the insiders did No buying or selling

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
John W Childs
Director
—
—
—
5,653,904
$48.15M
+150.3%
Vlad Coric
Chief Executive Officer
—
—
—
2,544,514
$21.67M
+36.5%
Gregory Bailey
Director
—
—
—
2,020,071
$17.20M
+24.7%
Matthew Buten
Chief Financial Officer
—
—
—
195,652
$1.67M
+1.7%
Kimberly Gentile
SVP, Clinical Operations
—
—
—
99,557
$847.82K
+3.7%
George C. Clark
VP, Chief Accounting Officer
—
—
—
86,978
$740.70K
+29.4%
Kishan Mehta
Director
—
—
—
22,662
$192.99K
0.0%
Bruce Car
Chief Scientific Officer
—
—
—
7,715
$65.70K
+163.6%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.